Clinical Trials
71 trialsUsing Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
Lumed
University Hospital, Basel, Switzerland
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
University of Miami
REPOTHYROID-II
Radboud University Medical Center
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
Providence Health & Services
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
City of Hope Medical Center
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
M.D. Anderson Cancer Center
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
Mayo Clinic
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
Emory University
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
F-Tryptophan PET/CT in Human Cancers
Barbara Ann Karmanos Cancer Institute
LANTana
Imperial College London
NEO-COMBATXL
UNC Lineberger Comprehensive Cancer Center
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
Stanford University
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
Case Comprehensive Cancer Center
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
AHS Cancer Control Alberta
A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens
Peking University Cancer Hospital & Institute
PRRT-PARPi
Erasmus Medical Center
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
The First Affiliated Hospital of Xiamen University
PARLuNET
Peter MacCallum Cancer Centre, Australia
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Cook Children's Health Care System
TARGET
University Medical Center Groningen
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
First Affiliated Hospital of Fujian Medical University
DEPARTURE
University Medical Center Groningen
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
University of Wisconsin, Madison
Impact of Acetazolamide in Reducing Referred Postoperative Pain
Medical College of Wisconsin
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Study of Everolimus (RAD001) in Combination With Lenalidomide
Emory University
Alcohol and Implicit Process in Sexual Risk Behavior in MSM
Syracuse University
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
M.D. Anderson Cancer Center
Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
University of Kentucky
Intraoperative Imaging of Pituitary Adenomas by OTL
University of Pennsylvania
A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors
Massachusetts General Hospital
Study of JS001 in Patients With Advanced Neuroendocrine Tumors
Peking University
FGR
Dartmouth-Hitchcock Medical Center
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
Emory University
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
Peking Union Medical College Hospital
177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital